Praziquantel (PZQ) is widely used to treat schistosomiasis. However, this chiral active pharmaceutical ingredient (API) is still produced as a racemic compound while only the (R)-enantiomer is active.

Coherent demodulation of a received signal requires the same carrier signal as the one used by the transmitter (TX). Thus, the RX needs to reconstruct the carrier from the received carrier-less signal ...

With positive data in both Phase 2 prophylaxis and on-demand studies in HAE, Pharvaris is currently evaluating the efficacy and safety of deucrictibant in a pivotal Phase 3 study for the prevention of ...

Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025 GlobeNewswire Jul. 10, 2025 18:50 158 ...

With positive data in both Phase 2 prophylaxis and on-demand studies in HAE, Pharvaris is currently evaluating the efficacy and safety of deucrictibant in a pivotal Phase 3 study for the ...

With positive data in both Phase 2 prophylaxis and on-demand studies in HAE, Pharvaris is currently evaluating the efficacy and safety of deucrictibant in a pivotal Phase 3 study for the ...

“The attack data in RAPIDe-3 have continued to accrue following the achievement of target enrollment in the study; we now estimate that our RAPIDe-3 topline data announcement will be in the ...

Peng Lu, M.D., Ph.D., Chief Medical Officer of Pharvaris, added, "We aim to confirm the findings from our Phase 2 studies in a larger Phase 3 trial, RAPIDe-3. Importantly, this study is assessing the ...

Due to the complex electromagnetic environment and the increased demand for frequency occupation, radio frequency interference (RFI) is becoming a significant issue for the bistatic synthetic aperture ...

Replacing analog solutions with scalable CMOS precision for AI, 5G, aerospace, and other challenging applications, Mixed-Signal Devices ' next-generation clock and timing portfolio is designed to meet ...